Clover Health Investments, Corp.

NASDAQ:CLOV

Medical - Healthcare Plans

Healthcare
$4.17 +3.54%

+$0.17 today

Market cap
$2.21B
Beta
2.48
P/E (TTM)
-45.6
EPS (TTM)
-$0.11
52W Low $1.58High $5.18

Volume 8.05M

Average 7.31M

CLOV Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Clover Health Investments, Corp.NASDAQ: CLOV

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 545.45M shares rose 7.2% year over year, ahead of the +6.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 2.4% from the prior quarter. Over 3 fiscal years it compounded at +2.8% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +7.2% holds above the trailing-twelve-month pace of +6.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
545.45M+2.4% QoQ
Last fiscal yearDec 2025
517.24M+5.6% YoY
LTMJun 2026
526.98M+6.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.2%——
1 year+5.6%——
3-year CAGR+2.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
517.24M USD
Year-over-year change
+5.6%
4-year CAGR
+2.4%

Weighted Avg Shares (Diluted) vs competitors

How CLOV compares with its peers on the latest reported figures

  • CLOV's LTM Jun 2026 weighted avg shares (diluted) of 526.98M shares is the 2nd highest of the 7 companies compared; the peer median is 282.95M shares.
  • Its year-over-year change of +6.0% is the 3rd highest of 7, against a peer median of +0.6%.
  • Over three fiscal years its annual growth of +2.8% compares with a peer median of -1.5%.
CLOV Competitors Peer median
Weighted Avg Shares (Diluted) for CLOV and competitors
Company Period LTM YoY 3-year CAGR
CVSCVS Health CorporationLTM Jun 20261.28B +1.1%-1.3%
CLOVClover Health Investments, Corp.LTM Jun 2026526.98M +6.0%+2.8%
CNCCentene CorporationLTM Jun 2026493.86M -2.1%-5.5%
OSCROscar Health, Inc.LTM Jun 2026301.43M +11.1%+7.3%
CICigna CorporationLTM Sep 2026264.48M -3.6%-5.3%
ALHCAlignment Healthcare, Inc.LTM Mar 2026208.14M +8.4%+3.0%
HUMHumana Inc.LTM Sep 2026120.93M +0.1%-1.7%
Peer median (excluding CLOV) 282.95M+0.6%-1.5%

Competitors are the stored peer set for CLOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.47B1.1B1.26B1.37B1.92B
Cost of Revenue1.55B993.07M1B1.01B1.57B
Gross Profit(79.18M)103.48M255.95M364.8M355.88M
Gross Margin-5.4%9.4%20.3%26.6%18.5%
Research & Development00000
Selling, General & Admin445.75M482.4M440.25M408.93M176.32M
Operating Expenses557.81M390.14M461.28M410.55M441.43M
Depreciation & Amortization1.25M1.19M2.51M1.33M1.69M
EBITDA(569.6M)(252.03M)(207.63M)(44.94M)(83.86M)
EBITDA Margin-38.7%-23.0%-16.5%-3.3%-4.4%
Operating Income(636.99M)(286.66M)(205.33M)(45.75M)(85.53M)
Operating Margin-43.3%-26.1%-16.3%-3.3%-4.4%
Interest Income00000
Interest Expense16.91M1.36M7K00
Other Income / Expenses49.24M32.08M(4.82M)(517K)(20K)
Income Before Tax(587.76M)(254.58M)(210.15M)(46.27M)(85.55M)
Pre-Tax Margin-39.9%-23.2%-16.7%-3.4%-4.4%
Income Tax Expense00000
Net Income(587.76M)(339.57M)(213.36M)(43.01M)(85.55M)
Net Margin-39.9%-31.0%-16.9%-3.1%-4.4%
EPS (Basic)(1.25)(0.71)(0.45)(0.09)(0.17)
EPS (Diluted)(1.25)(0.71)(0.45)(0.09)(0.17)
Weighted Avg Shares470.85M476.24M482.18M490.02M517.24M
Weighted Avg Shares (Diluted)470.85M476.24M482.18M490.02M517.24M

Clover Health Investments, Corp.

NASDAQ:CLOV

Intrinsic Alpha fair value

Locked

Current Price

$4.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.